Rhythm Pharmaceuticals (Boston, MA), a clinical-stage biotechnology company focused on peptide therapeutics for metabolic disorders, closed an $8M Series B financings, bringing the total round to $33M. Participants include Pfizer Ventures, MPM Capital, New Enterprise Associates, Third Rock Ventures and Ipsen Ventures.
Collective IP | The World’s Largest Technology Transfer Office Marketplace
Providing Unrivaled Comprehensive and Accurate Access to Humankinds Most Valuable and Transformative Assets
Receive Collective IP Account Access HERE